Publications by authors named "Fabio Rigo"

Claim this Profile
R
Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ART.
Elisa Dalla Grana, Fabio Rigo, Massimiliano Lanzafame, Emanuela Lattuada, Silvia Suardi

Front Endocrinol (Lausanne)· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life.
Emanuela Lattuada, Massimiliano Lanzafame, Stefano Nicolè, Fabio Rigo, Giulia Cucchetto

Int J STD AIDS· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up.
Massimiliano Lanzafame, Stefano Nicolè, Davide Gibellini, Emanuela Lattuada, Giulia Cucchetto, Fabio Rigo

J Antimicrob Chemother· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient.
Massimiliano Lanzafame, Emanuela Lattuada, Stefano Nicolè, Fabio Rigo, Giulia Cucchetto

Int J STD AIDS· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a reduced dose of DARUNAVIR/RTV in a cohort of antiretroviral-naïve and experienced HIV-infected patients: a medium-term follow-up.
Massimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, Andrew Hill, Sandro Vento

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated Mycobacterium avium complex disease in a patient with left ventricular assist device (Heart Mate II).
Maddalena Cordioli, Paola Del Bravo, Fabio Rigo, Anna Maria Azzini, Mara Merighi

Infez Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients.
Massimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, Stefano Nicole, Giulia Cucchetto

AIDS· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of Alere Determine HIV-1/2 Ag/Ab Combo rapid test for acute HIV infection: a case report.
Massimiliano Lanzafame, Antonella Zorzi, Fabio Rigo, Irene Adami, Paola Del Bravo

Infez Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up.
Massimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, Anna Ferrari, Andrew Hill

J Antimicrob Chemother· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A maintenance dose of atazanavir/ritonavir 200/100 mg once daily is effective in virologically suppressed HIV-1-infected patients.
Massimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, Sandro Vento

J Acquir Immune Defic Syndr· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a reduced dose of darunavir/ritonavir in a small cohort of antiretroviral-naïve HIV-infected patients.
Massimiliano Lanzafame, Emanuela Lattuada, Fabio Rigo, Sandro Vento

AIDS Patient Care STDS· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis